Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Health Products, Skin Care Products	70.25M	73.76M	62.84M	124.25M	210.76M
Cell services income	44.98M	41.97M	50.83M	48.03M	28.71M
Revenue From Cell Foundry	44.29M	33.11M	-	-	-
Inspection Income	27.52M	21.19M	27.51M	-	-
Other	-	-	-	8.39M	3.29M
Total	187.02M	170.03M	141.18M	180.67M	242.75M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	187.02M	170.03M	141.18M	180.67M	242.75M
Total	187.02M	170.03M	141.18M	180.67M	242.75M

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 4, 2026

Data Sources Report a data error